Pirfenidone Tablet, Film Coated
Product Images NDC 0480-3610

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 0480-3610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Image 1)

Chemical structure diagram of the active ingredient Pirfenidone, showing its molecular arrangement with aromatic rings and functional groups.*

FDA Label Image

Fig1 (Image 2)

A cumulative distribution plot depicting the percentage of patients versus absolute change in percent predicted forced vital capacity (%FVC) from baseline to week 52. The graph compares two groups: patients treated with Pirfenidone and those given a placebo. The X-axis shows %FVC change from -30 to 10, while the Y-axis shows the percent of patients from 0% to 100%. Markers on the graph highlight 32% versus 17% worsening and 90% versus 77% no decline in %FVC for placebo and Pirfenidone groups respectively.*

FDA Label Image

Fig2 (Image 3)

A line graph comparing mean change in Forced Vital Capacity (FVC) in milliliters over 52 weeks between a group treated with Pirfenidone (n=278) and a placebo group (n=277). The graph shows data points at weeks 0, 13, 26, 39, and 52, with both groups experiencing a decline in FVC, but the Pirfenidone group showing a slower decrease compared to placebo.*

FDA Label Image

New (Image 4)

A Kaplan-Meier survival curve comparing the percentage of patients alive over time (weeks) between Pirfenidone (n=623) and placebo (n=624) groups. The graph includes patient counts at risk at various time points and a hazard ratio with 95% confidence interval (HR=0.75, 95% CI 0.51-1.11).*

FDA Label Image

267mg270 (Image 5)

Label for Pirfenidone Tablets 267 mg film-coated tablet, containing 270 tablets in the package. The label includes storage instructions, dispensing warnings, and manufacturer details, identifying Teva Pharmaceuticals, Inc. as the labeler and Watson Pharma Private Limited in India as the manufacturer. The label also features barcode and product NDC 0480-3610-87.*

FDA Label Image

801mg90s (Image 6)

Label for Pirfenidone Tablets 801 mg, film-coated, with a package size of 90 tablets. The label includes storage instructions, dosage guidance referencing the package insert, and manufacturer details. Manufactured in India by Watson Pharma Pvt Ltd for Teva Pharmaceuticals, Inc. A barcode and serialization coding area are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.